Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15303190> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q15303190 subject Q8529502.
- Q15303190 abstract "Batimastat (INN/USAN, codenamed BB-94) is an anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. It acts as a matrix metalloproteinase inhibitor (MMPI) by mimicking natural MMPI peptides.Batimastat was the first MMPI that went into clinical trials. First results of a Phase I trial appeared in 1994. The drug reached Phase III but was never marketed; mainly because it couldn't be administered orally (as opposed to the newer and chemically similar MMPI marimastat), and injection into the peritoneum caused peritonitis.".
- Q15303190 atcPrefix "none".
- Q15303190 casNumber "130370-60-4".
- Q15303190 drugbank "DB03880".
- Q15303190 iupacName "(2R,3S)-N4-Hydroxy-2-isobutyl-N1-[(2S)-1-(methylamino)-1-oxo-3-phenyl-2-propanyl]-3-[(2-thienylsulfanyl)methyl]succinamide".
- Q15303190 pubchem "5362422".
- Q15303190 thumbnail Batimastat_skeletal.svg?width=300.
- Q15303190 wikiPageWikiLink Q16966320.
- Q15303190 wikiPageWikiLink Q172847.
- Q15303190 wikiPageWikiLink Q192398.
- Q15303190 wikiPageWikiLink Q223102.
- Q15303190 wikiPageWikiLink Q30612.
- Q15303190 wikiPageWikiLink Q4926095.
- Q15303190 wikiPageWikiLink Q574834.
- Q15303190 wikiPageWikiLink Q6763659.
- Q15303190 wikiPageWikiLink Q824258.
- Q15303190 wikiPageWikiLink Q8529502.
- Q15303190 wikiPageWikiLink Q9597.
- Q15303190 atcPrefix "none".
- Q15303190 casNumber "130370".
- Q15303190 drugbank "DB03880".
- Q15303190 iupacName "-N4-Hydroxy-2-isobutyl-N1-[-1--1-oxo-3-phenyl-2-propanyl]-3-[methyl]succinamide".
- Q15303190 pubchem "5362422".
- Q15303190 type ChemicalSubstance.
- Q15303190 type Drug.
- Q15303190 type ChemicalObject.
- Q15303190 type Thing.
- Q15303190 type Q8386.
- Q15303190 comment "Batimastat (INN/USAN, codenamed BB-94) is an anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. It acts as a matrix metalloproteinase inhibitor (MMPI) by mimicking natural MMPI peptides.Batimastat was the first MMPI that went into clinical trials. First results of a Phase I trial appeared in 1994.".
- Q15303190 label "Batimastat".
- Q15303190 depiction Batimastat_skeletal.svg.